Novel INXN-4001 Triple Effector Plasmid in Heart Failure
Clinical trial NCT03409627 · COMPLETED
Trial details
- NCT number
- NCT03409627
- Sponsor
- Triple-Gene, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-09
- Primary completion
- 2020-03-04
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.